We can’t show the full text here under this license. Use the link below to read it at the source.
Specialist Healthcare Intervention and Follow-up Trends in Post-Acute COVID-19 Hospitalization as Compared to Other Respiratory Infections
Specialist Care and Follow-up Patterns After Hospitalization for COVID-19 Compared to Other Lung Infections
AI simplified
Abstract
Among 57,795 hospitalized patients, 75.8% of those with COVID-19 had at least one specialist visit post-discharge.
- COVID-19 patients were younger and had lower rates of comorbidities and post-discharge mortality (10.7% vs. 33.5%).
- They experienced longer waits for specialist visits, with a median of 63 days compared to 45 days for other ARIs.
- Patients hospitalized for COVID-19 underwent more imaging and spirometry tests but started fewer chronic medications overall.
- Notably, the prescription rates for antidiabetics, psychoanaleptics, and genitourinary/hormonal drugs were higher after COVID-19 hospitalizations.
- Patients with other ARIs were more likely to be hospitalized for reasons unrelated to COVID-19.
AI simplified
Key numbers
10.7%
12-month Mortality Rate
Mortality rate for COVID-19 patients vs. 33.5% for other ARIs.
75.8%
Specialist Visit Rate
COVID-19 patients vs. 70.3% for other ARIs.
63 days
Median Time to First Specialist Visit
Compared to 45 days for other ARIs.